Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
NCT00086593
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
209
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
lamotrigine
Sponsor
GlaxoSmithKline